Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-10

Clinical Trial Update: Lipogems Prospective Study [Phase 4]

View source ↗

Summary

A Phase 4 prospective study of Lipogems for knee osteoarthritis was terminated; results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipogems (microfragmented adipose tissue)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Knee Osteoarthritis | Phase 4 | Status: TERMINATED | Results posted: 2023-02-10